BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2020
View Archived Issues
Antigen agnostic tolerizing therapy in MS
Read More
Small-molecule compound targets amyloid beta
Read More
FDA places IND on hold for PRAX-114 in major depressive disorder
Read More
BRKB-28 shows promising in vitro efficacy in breast and gastric cancer
Read More
Phase I data reported for Medicago's COVID-19 vaccine candidate
Read More
Preliminary phase I data for AT-301 nasal spray being developed for COVID-19
Read More
Ariagen patents AhR agonists for cancer
Read More
Janssen Pharmaceutica discloses BARK1 inhibitors
Read More
Colorado Research Partners identifies KHK inhibitors
Read More
NiKang Therapeutics synthesizes new HIF-2alpha inhibitors
Read More
New oncolytic adenoviral vectors presented by Targovax
Read More
SHR-0302 displays dose-dependent effects in rheumatoid arthritis
Read More
First-in-human data for LNA-043 as treatment of knee osteoarthritis
Read More
Rallybio begins phase I/II study of RLYB-211 for fetal and neonatal alloimmune thrombocytopenia
Read More
Phase II trial of bemarituzumab in gastric or GEJ cancer meets primary endpoints
Read More
Promising phase II data for deucravacitinib in active psoriatic arthritis
Read More
[64Cu]DOTA-UBI 29-41 for imaging of active infectious processes
Read More
First phase IIa data presented on AR-882, a potent and selective uricosuric drug
Read More
Small molecule targets same repeat expansion in distinct diseases
Read More
Corbus reports post-hoc analyses of RESOLVE-1 study of lenabasum for systemic sclerosis
Read More
Ono initiates phase III study of Foipan for COVID-19
Read More